Recipient Title General Manager Quality Assurance Department, 1 Chome 14-41 Nishihashimoto, Midori Sagamihara , Kanagawa JapanFEI 3010960168Issued Jun 2, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3010960168.
Violations4
Issue DateJun 2, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Asanuma Corporation - Sagamihara Factory
Location
Recipient Title General Manager Quality Assurance Department, 1 Chome 14-41 Nishihashimoto, Midori Sagamihara , Kanagawa Japan
FEI Number
3010960168
Country
Japan
Issue Date
June 02, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/OTC Finished Pharmaceuticals/Adulterated
Asanuma Corporation - Sagamihara Factory FDA Warning Letter, June 2, 2026
Talk to a Specialist